LOX exacerbates vascular inflammation and endothelial dysfunction by activating the nuclear factor-κB (NF-κB) pathway, culminating in the secretion of pro-inflammatory cytokines, including interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) (98). Here, IL6 is linked to inflammatory response.